GlassScriptPhysician profile
Jason Christopher Lee
NPI 1326321050
$612.26
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $195 · 2021: $11.61 · 2022: $15.74.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $178.09 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.98 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $147.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.63 | 2019 | |
| Vapotherm INC | $11.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.